Omnicell Statistics
Total Valuation
Omnicell has a market cap or net worth of $1.65 billion. The enterprise value is $1.67 billion.
| Market Cap | 1.65B |
| Enterprise Value | 1.67B |
Important Dates
The last earnings date was Thursday, October 30, 2025, before market open.
| Earnings Date | Oct 30, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Omnicell has 44.88 million shares outstanding. The number of shares has increased by 2.08% in one year.
| Current Share Class | 44.88M |
| Shares Outstanding | 44.88M |
| Shares Change (YoY) | +2.08% |
| Shares Change (QoQ) | -2.31% |
| Owned by Insiders (%) | 2.41% |
| Owned by Institutions (%) | 101.41% |
| Float | 43.77M |
Valuation Ratios
The trailing PE ratio is 86.17 and the forward PE ratio is 20.84. Omnicell's PEG ratio is 2.42.
| PE Ratio | 86.17 |
| Forward PE | 20.84 |
| PS Ratio | 1.44 |
| Forward PS | 1.32 |
| PB Ratio | 1.35 |
| P/TBV Ratio | 6.44 |
| P/FCF Ratio | 14.76 |
| P/OCF Ratio | 10.73 |
| PEG Ratio | 2.42 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 22.21, with an EV/FCF ratio of 15.00.
| EV / Earnings | 83.93 |
| EV / Sales | 1.42 |
| EV / EBITDA | 22.21 |
| EV / EBIT | 90.32 |
| EV / FCF | 15.00 |
Financial Position
The company has a current ratio of 1.44, with a Debt / Equity ratio of 0.17.
| Current Ratio | 1.44 |
| Quick Ratio | 0.96 |
| Debt / Equity | 0.17 |
| Debt / EBITDA | 2.42 |
| Debt / FCF | 1.86 |
| Interest Coverage | 3.65 |
Financial Efficiency
Return on equity (ROE) is 1.62% and return on invested capital (ROIC) is 0.71%.
| Return on Equity (ROE) | 1.62% |
| Return on Assets (ROA) | 0.54% |
| Return on Invested Capital (ROIC) | 0.71% |
| Return on Capital Employed (ROCE) | 1.24% |
| Revenue Per Employee | $320,910 |
| Profits Per Employee | $5,428 |
| Employee Count | 3,670 |
| Asset Turnover | 0.55 |
| Inventory Turnover | 6.54 |
Taxes
In the past 12 months, Omnicell has paid $14.31 million in taxes.
| Income Tax | 14.31M |
| Effective Tax Rate | 41.80% |
Stock Price Statistics
The stock price has decreased by -20.23% in the last 52 weeks. The beta is 0.84, so Omnicell's price volatility has been lower than the market average.
| Beta (5Y) | 0.84 |
| 52-Week Price Change | -20.23% |
| 50-Day Moving Average | 32.45 |
| 200-Day Moving Average | 31.89 |
| Relative Strength Index (RSI) | 64.15 |
| Average Volume (20 Days) | 469,385 |
Short Selling Information
The latest short interest is 2.18 million, so 4.86% of the outstanding shares have been sold short.
| Short Interest | 2.18M |
| Short Previous Month | 1.91M |
| Short % of Shares Out | 4.86% |
| Short % of Float | 4.98% |
| Short Ratio (days to cover) | 5.12 |
Income Statement
In the last 12 months, Omnicell had revenue of $1.18 billion and earned $19.92 million in profits. Earnings per share was $0.43.
| Revenue | 1.18B |
| Gross Profit | 516.04M |
| Operating Income | 18.51M |
| Pretax Income | 34.23M |
| Net Income | 19.92M |
| EBITDA | 75.26M |
| EBIT | 18.51M |
| Earnings Per Share (EPS) | $0.43 |
Balance Sheet
The company has $180.05 million in cash and $206.78 million in debt, giving a net cash position of -$26.73 million or -$0.60 per share.
| Cash & Cash Equivalents | 180.05M |
| Total Debt | 206.78M |
| Net Cash | -26.73M |
| Net Cash Per Share | -$0.60 |
| Equity (Book Value) | 1.22B |
| Book Value Per Share | 27.21 |
| Working Capital | 203.03M |
Cash Flow
In the last 12 months, operating cash flow was $153.26 million and capital expenditures -$41.79 million, giving a free cash flow of $111.47 million.
| Operating Cash Flow | 153.26M |
| Capital Expenditures | -41.79M |
| Free Cash Flow | 111.47M |
| FCF Per Share | $2.48 |
Margins
Gross margin is 43.82%, with operating and profit margins of 1.57% and 1.69%.
| Gross Margin | 43.82% |
| Operating Margin | 1.57% |
| Pretax Margin | 2.91% |
| Profit Margin | 1.69% |
| EBITDA Margin | 6.39% |
| EBIT Margin | 1.57% |
| FCF Margin | 9.46% |
Dividends & Yields
Omnicell does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.08% |
| Shareholder Yield | -2.08% |
| Earnings Yield | 1.21% |
| FCF Yield | 6.78% |
Analyst Forecast
The average price target for Omnicell is $42.00, which is 14.57% higher than the current price. The consensus rating is "Buy".
| Price Target | $42.00 |
| Price Target Difference | 14.57% |
| Analyst Consensus | Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | 4.04% |
| EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Omnicell has an Altman Z-Score of 2.43 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.43 |
| Piotroski F-Score | 7 |